Ignite Creation Date:
2025-12-24 @ 12:58 PM
Ignite Modification Date:
2026-02-22 @ 7:24 AM
Study NCT ID:
NCT00805961
Status:
COMPLETED
Last Update Posted:
2021-12-08
First Post:
2008-12-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM
Sponsor:
SCRI Development Innovations, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-01
Start Date Type:
None
Primary Completion Date:
2009-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-05
Completion Date Type:
ACTUAL
First Submit Date:
2008-12-09
First Submit QC Date:
None
Study First Post Date:
2008-12-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-08-22
Results First Submit QC Date:
None
Results First Post Date:
2012-09-21
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-08
Last Update Post Date:
2021-12-08
Last Update Post Date Type:
ACTUAL